Singapore markets closed

Adaptimmune Therapeutics plc (ADAP)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
1.3900+0.0900 (+6.92%)
At close: 04:00PM EDT
1.4200 +0.03 (+2.16%)
After hours: 07:30PM EDT
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Assets
Current assets
Cash
Cash and cash equivalents
143,991
108,033
149,948
56,882
-
Other short-term investments
2,947
96,572
219,632
311,335
-
Total cash
146,938
204,605
369,580
368,217
-
Net receivables
821
7,435
752
139
-
Inventory
-
-
-
2,086
1,459
Other current assets
3,741
3,206
2,828
2,530
-
Total current assets
207,552
255,370
415,458
398,152
-
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
130,948
119,593
94,875
77,755
-
Accumulated depreciation
-59,240
-48,058
-43,506
-31,097
-
Net property, plant and equipment
71,708
71,535
51,369
46,658
-
Intangible assets
330
442
1,000
1,730
-
Other long-term assets
3,026
1,569
1,718
4,602
-
Total non-current assets
75,064
73,546
54,087
52,990
-
Total assets
282,616
328,916
469,545
451,142
-
Liabilities and stockholders' equity
Liabilities
Current liabilities
Accounts payable
8,128
4,753
8,113
6,389
-
Accrued liabilities
15,628
20,828
17,824
15,207
-
Deferred revenues
28,973
23,520
22,199
2,832
-
Other current liabilities
51
2,155
327
47
-
Total current liabilities
72,788
64,501
62,541
39,073
-
Non-current liabilities
Deferred revenues
149,060
160,892
177,223
49,260
-
Other long-term liabilities
1,404
1,296
673
644
-
Total non-current liabilities
170,315
182,537
201,044
70,842
-
Total liabilities
243,103
247,038
263,585
109,915
-
Stockholders' equity
Common stock
1,865
1,399
1,337
1,325
-
Retained earnings
-1,023,173
-909,302
-743,846
-585,756
-
Accumulated other comprehensive income
-3,748
-875
-11,142
-10,048
-
Total stockholders' equity
39,513
81,878
205,960
341,227
-
Total liabilities and stockholders' equity
282,616
328,916
469,545
451,142
-